🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this study is to evaluate the performance of Medacta Anatomic R...
Status
Recruiting
Location
Praxis Gelenkpunkt - Sport- und Gelenkchirurgie
Start Date
2022-07-01
Trial ID
NCT04462458
Treatments Being Tested
The study aims to evaluate the potential clinical impact of a highly sensit...
Status
Active Not Recruiting
Location
Hospital of West Jutland
Start Date
2019-11-01
Trial ID
NCT04100733
Treatments Being Tested
Randomised, controlled clinical study to assess the efficacy and tolerabili...
Status
Completed
Location
Gynaecology Department, Medical Service Ishtar
Start Date
2023-05-15
Trial ID
NCT06987396
Treatments Being Tested
The primary objective of this prospective, single-centre study is to establ...
Status
Completed
Location
Urology and Nephrology Center
Start Date
2018-03-01
Trial ID
NCT03715660
Treatments Being Tested
The present trial was aimed to identify which biomarkers could be associate...
Status
Completed
Location
Multiple Locations
Start Date
2011-01-01
Trial ID
NCT03459261
Anastomotic leakage is a clinically important complication following laparo...
Status
Completed
Location
Alexandria main university hospital
Start Date
2022-12-15
Trial ID
NCT07722533
This study is a stepped-wedge cluster-randomized trial of on-site rapid tes...
Status
Terminated
Location
Mary's Place Burien
Start Date
2019-11-15
Trial ID
NCT04141917
Treatments Being Tested
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
Total hip replacement (THR) is a highly effective procedure in relieving pa...
Status
Unknown
Location
Charing Cross hospital
Start Date
2012-10
Trial ID
NCT01721278
The main purpose of REVLIMID® DUE (Drug Use Examination) is to collect and ...
Status
Completed
Location
Hallym University Sacred Heart Hospital
Start Date
2011-03-09
Trial ID
NCT02556905
Treatments Being Tested